Venus Medtech (Hangzhou) Inc. (VMTHF)
OTCMKTS · Delayed Price · Currency is USD
0.4219
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Venus Medtech (Hangzhou) Market Cap
Venus Medtech (Hangzhou) has a market cap or net worth of $161.33 million as of February 12, 2026. Its market cap has decreased by -28.59% in one year.
Market Cap
161.33M
Enterprise Value
189.41M
Revenue
59.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.42
Market Cap Chart
Since December 10, 2019, Venus Medtech (Hangzhou)'s market cap has decreased from 2.16B to 161.33M, a decrease of -92.53%. That is a compound annual growth rate of -34.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 161.32M | 20.48% |
| Dec 31, 2025 | 133.90M | -83.28% |
| Dec 30, 2022 | 800.84M | -51.82% |
| Dec 31, 2021 | 1.66B | -61.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 340.99M |
| Tian'an Technology Group | 145.66M |
| Zomedica | 124.94M |
| Positron | 68.49M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 55.94M |
| Vivos | 32.75M |
| Guided Therapeutics | 28.51M |